Highbridge Capital Management’s Eli Lilly LLY Stock Holding History

Highbridge Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,700	Closed	-$405K	–	706
2018 Q2	$405K	Buy	+4,700	New	+$386K	0.01%	637
2017 Q3	–	Sell	-3,000	Closed	-$247K	–	1672
2017 Q2	$247K	Sell	3,000 -2,600	-46%	-$212K	﹤0.01%	1034
2017 Q1	$470K	Buy	+5,600	New	+$449K	0.01%	930
2016 Q1	–	Sell	-12,600	Closed	-$1.06M	–	1669
2015 Q4	$1.06M	Sell	12,600 -41,900	-77%	-$3.48M	0.02%	727
2015 Q3	$4.56M	Sell	54,500 -4,300	-7%	-$363K	0.07%	325
2015 Q2	$4.91M	Buy	+58,800	New	+$4.48M	0.06%	314
2014 Q3	–	Sell	-4,600	Closed	-$285K	–	1280
2014 Q2	$285K	Sell	4,600 -20,400	-82%	-$1.22M	﹤0.01%	886
2014 Q1	$1.47M	Sell	25,000 -51,000	-67%	-$2.85M	0.02%	466
2013 Q4	$3.88M	Buy	76,000 +68,200	+874%	+$3.42M	0.05%	310
2013 Q3	$392K	Buy	+7,800	New	+$408K	﹤0.01%	961

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Highbridge Capital Management's LLY Position: Q4 2018 in Review

Highbridge Capital Management sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 26,779 shares — an estimated $2.87M sold.

Highbridge Capital Management first reported a position in LLY in Q2 2013 and held it in 11 quarters. The position peaked at $46.4M in Q4 2013. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

Highbridge Capital Management reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 26,779 Eli Lilly shares in Q4 2018, an estimated $2.87M.
Highbridge Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 11 quarters.
Highbridge Capital Management's Eli Lilly position peaked at $46.4M in Q4 2013.
1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.